Live news related to NICOX stock (FR0013018124): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
On Tuesday, Nicox unveiled favorable Phase 3 clinical data for NCX 470, its leading development program. These results were presented at the 2026 annu…
Nicox has announced receiving positive written feedback from the U.S. Food and Drug Administration (FDA) following its pre-NDA meeting on NCX 470, an …
Nicox SA, an international ophthalmology company, has confirmed its eligibility for the PEA-PME scheme for the upcoming year. This confirmation allows…
Nicox announces the presentation of its Phase 3 study results on NCX 470 at the 2026 annual meeting of the American Glaucoma Society, scheduled from F…
The ophthalmic laboratory Nicox will participate in several scientific and financial congresses between January and June 2026. The company will notabl…
Nicox shares closed up 12% on Monday, January 5, following the full repayment of secured debt to Kreos Capital, boosting investor confidence and finan…
Ophthalmology company Nicox has announced the full repayment of its secured debt with Kreos Capital and has obtained a new bond financing of 4 million…
The ophthalmic laboratory Nicox has announced the completion of data generation and analysis necessary for the submission of marketing authorization a…
Nicox S.A., specializing in ophthalmology, has released its financial results for the first half of 2025, reporting a decrease in revenue compared to …
